Urinary excretion of heparan sulphate proteoglycan (HSPG), the main anionic component of the glomerular basement membrane (GBM), was estimated in 30 adolescents and young adults with insulin dependent diabetes (IDDM), 10 with microalbuminuria and 20 sex matched, diabetic controls of similar age without evidence of microalbuminuria. A further 10 non-diabetic control subjects were also examined. Both groups of patients with diabetes had significantly elevated excretion of HSPG when compared to normal individuals. There was no difference in HSPG excretion between diabetic subjects with and without microalbuminuria.
KanwarYSFarquharMG. Presence of heparan sulphate in glomerular basement membrane. Proc Natl Acad Sci USA1979; 76: 4493–7.
2.
DeckertTKofoed-EnveoldsenAVidalPNorgaardKAndreasenHBFeldt-RasmussenB.Size and charge selectivity of glomerular filtration in Type 1 diabetic patients with and without albuminuria. Diabetologia1993; 36: 244–51.
3.
MathiesenEROxenballBJohansenKSvendsenPAaDeckertT.Incipient nephropathy in type 1 diabetes. Diabetologia1984; 26: 406–10.
4.
ParthasarathyNSpiroRG. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes1982; 31: 738–41.
5.
NerlichASchleicherE.Immunohistochemical localisation of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol1991; 139: 889–99.
6.
ShimomuraHSpiroRG. Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Diabetes1987; 36: 374–81.
7.
RohrbachDHHassellJRKleinmanHYMartinGR. Alterations in the basement membrane (heparan sulphate) proteoglycan in diabetic mice. Diabetes1982; 31: 185–8.
8.
KleinDJBrownDMOegemaTR. Glomerular proteoglycans in diabetes. Diabetes1986; 35: 1130–41.
9.
TarsioJFRegerLAFurchtLT. Molecular mechanisms in basement membrane complications in diabetes. Diabetes1988; 37: 532–9.
10.
AlmdalTNorgaardKFeldt-RasmussenBDeckertT.The predictive value of microalbuminuria in IDDM. Diabetes Care1994; 17: 120–5.
11.
PennockCAMottMGBatstoneGF. Screening for mucopolysaccharidoses. Clin Chim Acta1970; 27: 93–7.
12.
WhitleyCBRidmourMDDraperKADuttonCMNegliaJP. Diagnostic test for mucopolysaccharidosis—1. Direct method for quantifying excessive urinary glycosaminoglycan excretion. Clin Chem1989; 35: 374–9.
13.
de JongJGNWeversRALaarakkersCPoorthulsBJHM. Dimethylmethylene blue based spectrophotometry of glycosaminoglycans in untreated urine: A rapid screening procedure for mucopolysaccharidoses. Clin Chem1989; 35: 1472–7.
14.
YamagataTSaitoHHabuchiOSuzukiS.Purification and properties of bacterial chondroitinases and chondrosulphatases. J Biol Chem1968; 243: 1523–35.
HayashiYMakinoHOtaZ.Serum and urinary concentrations of Type IV collagen and laminin as a marker of microangiopathy in diabetes. Diabetic Med1992; 9: 366–70.
17.
DeckertTHorowitzIMKofoed-EnevoldsenAKjellenLDeckertMLykkelundCPossible genetic defects in regulation of glycosaminoglycans in patients with diabetic nephropathy. Diabetes1991; 40: 764–70.
